Aspen Neuroscience
PrivateLast Round
Series C
11/20/2025
Total Funding Raised
$387M
Company Overview
Aspen Neuroscience is a biotechnology company that develops autologous cell therapies and personalized medicines aimed at treating a wide range of diseases, beginning with Parkinson's disease, through the use of advanced genomic AI and pluripotent stem cell biology for patient-specific restorative treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery, Medical AI
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspen Neuroscience Comps
Public and private peers based on sector, stage, and business model.
Aspen Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | 11/20/2025 | ||||
| Grant | 5/15/2024 | ||||
| Debt | 12/21/2022 | ||||
| Series B | 5/9/2022 | ||||
| Series A | 4/1/2020 | ||||
Seed | 12/12/2019 |
Key People
Founding team and executive leadership
Aspen Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Seed, Series C, Series A |
| Prebys Ventures Impact Fund | Series C |
| Balyasny Asset Management L.P. | Series C |
| Prebys Ventures | Series C |
| Frazier Healthcare Partners | Series A |
| GV | Series B |
| BioVerge Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
New 12-month data released from ASPIRO trial of sasineprocel.
- Mar 18, 2026
Presented at the AD/PD 2026 International Conference in March 2026.
Aspen Neuroscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aspen Neuroscience's valuation, stock price, and market status.
